Stockreport

Capricor surges on plans to seek FDA approval for lead asset [Seeking Alpha]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF The San Diego, California-based biotech said it would begin the filing of a biologics license application (BLA) in October targeting FDA approval for deramiocel in card [Read more]